Christopher W Smith

3PUBLICATIONS
15CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 14, 2022
The Btk inhibitor AB-95-LH34 potently inhibits atherosclerotic plaque-induced thrombus formation and platelet procoagulant activity.

Christopher W Smith, Maan H Harbi, Lourdes Garcia-Quintanilla

|Jul 27, 2022
Anti-GPVI nanobody blocks collagen- and atherosclerotic plaque-induced GPVI clustering, signaling, and thrombus formation.

Natalie J Jooss, Christopher W Smith, Alexandre Slater

|May 06, 2022
Anti-platelet factor 4 immunoglobulin G levels in vaccine-induced immune thrombocytopenia and thrombosis: Persistent positivity through 7 months.

Samantha J Montague, Christopher W Smith, Clare S Lodwick

Pageof 1